-
Trump's tariffs could raise the cost of generic drugs in the U.S.
The cost of generic drugs for many people could go up if President-elect Donald Trump follows through on his promise to impose sweeping tariffs on products from China and other foreign countries, policy experts say.
-
Walking pneumonia surging among children, CDC says
Cases of walking pneumonia have spiked among children in recent months. News4’s Erika Gonzalez explains what parents should know.
-
Cases of walking pneumonia are surging among children. Here are the symptoms to watch
A spike in cases of walking pneumonia among young children has led the Centers for Disease Control and Prevention to issue an alert. The CDC reports emergency room visits for children with respiratory infections caused by the bacteria Mycoplasma pneumoniae have been rising rapidly in recent months. Cases among children 2 to 4 years old increased from 1% in April…
-
Clinical trials sparking hope for Alzheimer's patients: ‘Holding my own'
A clinical trial is testing whether an existing drug could benefit patients with Alzheimer’s disease, in hopes of making symptom-improving medication more accessible for people experiencing mild cognitive impairment.
-
Latina nurse helping moms when they need it most
A Mexican-American labor and delivery nurse at Sibley Memorial Hospital pursues her passion with language and culture.
-
Latina nurse helping moms when they need it most
Labor and delivery nurse Melissa Flores Barajas hopes to impact more patients in her community through her language and culture. News4’s Erika Gonzalez reports.
-
Surgeons in Philadelphia successfully separate conjoined twin boys
After spending nearly a year at Children’s Hospital of Philadelphia, conjoined twins Amari and Javar Ruffin were successfully separated.
-
Remember the prescription drug shortages from last year? The problem hasn't gone away
Forty years after the Hatch-Waxman Act created a market for affordable generic versions of prescription medications, it is struggling with persistent shortages.
-
Breast cancer rate rising in Asian American women
A new study from MedStar Health shows the majority of women aren’t getting their annual mammograms, and according to the American Cancer Society, breast cancer rates are rising the highest in Asian American women. News4’s Aimee Cho shares one survivor’s emotional journey.
-
Breast cancer rates rising highest among Asian American women
A new study from MedStar Health shows the majority of women aren’t getting their annual mammograms.
-
-
New hypertension treatment could reduce medication needed for some patients
D.C.-area doctors are trying a new approach on their toughest-to-treat patients. It’s even helping medical professionals who have hypertension. News4’s Erika Gonzalez reports.
-
New hypertension treatment could reduce medication needed for some patients
D.C.-area doctors are trying a new approach to hypertension on their toughest-to-treat patients.
-
Maker of Ozempic and Wegovy faces grilling over high cost of weight loss drugs
Is Novo Nordisk helping Americans save taxpayer money or ripping them off? The company’s CEO is scheduled to testify Tuesday on Capitol Hill.
-
Doctors soon required to tell mammogram patients about breast density
Soon, doctors must tell their mammogram patients if they have dense breast tissue, a factor that can make it harder to detect breast cancer and put them at greater risk for cancer. The Food and Drug Administration released new standards in March of 2023 in an effort to help more women detect breast cancer sooner. The FDA gave providers until…
-
What to know about a new mammogram regulation
A D.C. woman who is a two-time breast cancer survivor says for a long time she didn’t know she had dense breast tissue. A new rule aims to provide more people with the knowledge about their breast density. News4’s Aimee Cho reports.
-
Eli Lilly's weight loss drug slashes the risk of developing diabetes in long-term trial
The late-stage trial on tirzepatide also found that patients experienced sustained weight loss over the roughly three-year treatment period.
-
FDA approves new treatment for people with hemophilia B
There’s a new hope for people living with the rare blood disorder hemophilia B. The FDA recently approved a new gene therapy treatment for those who suffer from the debilitating condition. Dave Robinson, a 61-year-old IT consultant from Falls Church, Virginia, was born with the rare genetic blood disorder caused by an insufficient level of a protein known as...
-
FDA approves new treatment for people with hemophilia B
A man from Falls Church, Virginia who was born with Hemophilia B shares his reaction towards a clinical trial for a single infusion that changed the course of his life and could help others like him. News4’s Eun Yang has the story.
-
Howard University and 3 other HBCU medical schools to get $600M
Four historically Black medical schools, including Howard University, will receive a $600 million gift from Bloomberg Philanthropies, according to a press release on Tuesday. The four medical schools are Charles R. Drew University of Medicine & Science, Howard University College of Medicine, Meharry Medical College and Morehouse School of Medicine. The company will also provide seed funding to support the…